Literature DB >> 2856781

Renal effects of calcium antagonists in hypertensive patients.

G Leonetti1, A Zanchetti.   

Abstract

This summary report of various clinical studies by our group describes the effects on renal excretion of water and sodium of several different calcium antagonists (verapamil, gallopamil, nifedipine and felodipine) which were administered for variable periods of time (from a single administration to repeated doses over up to 10 days) to hypertensive patients. All calcium antagonists tested displayed some diuretic and natriuretic action, despite profound differences in chemical nature and in pharmacodynamic properties. On single-dose administration the renal action of calcium antagonists was prompt, appearing during the first few hours, and decaying and ending after 6 h. When repeated doses were administered over several days the effect was at a maximum during the first 2 days and then disappeared in the following days, but the negative sodium balance which developed during the first 2 days was maintained for at least 7-10 days. The natriuretic effect was not accompanied by any change in the glomerular filtration rate, but with felodipine, a natriuretic effect observed at small doses reverted to an antinatriuretic effect at higher doses, at which the glomerular filtration rate was slightly decreased.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2856781

Source DB:  PubMed          Journal:  J Hypertens Suppl        ISSN: 0952-1178


  4 in total

Review 1.  Felodipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension.

Authors:  E Saltiel; A G Ellrodt; J P Monk; M S Langley
Journal:  Drugs       Date:  1988-10       Impact factor: 9.546

2.  Hemodynamic interactions between diuretics and calcium antagonists in the treatment of hypertensive patients.

Authors:  S Di Somma; V Liguori; M Petitto; G Cavallotti; S Savonitto; O de Divitiis
Journal:  Cardiovasc Drugs Ther       Date:  1990-08       Impact factor: 3.727

Review 3.  Future prospects for calcium antagonists.

Authors:  S Kazda
Journal:  Drugs       Date:  1994       Impact factor: 9.546

4.  Hypertension therapy--an update.

Authors:  R B Cubberley
Journal:  J Natl Med Assoc       Date:  1987-11       Impact factor: 1.798

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.